Licence agreements for commercialisation of Ayush 64 & Ayush

The government today entered into License Agreements with Dabur India Ltd for commercialisation of malaria and diabetes drug Ayush 64 and Ayush 82 respectively.
Ayush-64 is an ayurvedic formulation for treatment of Malaria and while Ayush-82 is for management of diabetes .
The agreement was signed between the National Research Development Corporation (NRDC), an Enterprise of the Department of Scientific & Industrial Research, Ministry of Science & Technology and Dabur India Ltd.
The drugs Ayush 64 and Ayush 82 were developed by Central Council for Research in Ayurvedic Sciences (CCRAS), New Delhi, an autonomous body of the Ministry of AYUSH (Ayurveda, Yoga and naturopathy, Unani, Siddha and Homeopathy).

The Ayurvedic Drug Ayush-64 is very effective for the treatment of Malaria.
In view of its wide prevalence and drug resistant malarial parasite, a poly-herbal non-toxic drug has been developed by CCRAS after carrying out extensive pharmacological, toxicological and clinical studies.
Ayush-82 is a combination of known and tested hypoglycemic drugs.